Steven M Albelda MD
Critical Care Medicine, Pleural Disease
Professor, Medicine, Perelman School of Medicine
Join to view full profile
3450 Hamilton Walk228 Stemmler HallPhiladelphia, PA 19104
Phone+1 215-573-9933
Fax+1 215-746-0376
Dr. Albelda is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1985- University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
Perelman School of Medicine at the University of PennsylvaniaClass of 1979
Certifications & Licensure
PA State Medical License 1981 - 2018
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1995
Publications & Presentations
PubMed
- A dual diacylglycerol kinase (DGK) alpha/zeta inhibitor augments the activity of human tumor infiltrating lymphocytes inandmodels.Phurin Areesawangkit, Karen Pei-Yi Fong, Emma Niemeyer, Yan Li, Kelly Markowitz
Oncoimmunology. 2026-12-31 - 12 citationsA tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors.Haijiao Liu, Estela Noguera-Ortega, Xuanqi Dong, Won Dong Lee, Jeehan Chang
Nature Biotechnology. 2026-06-01 - 2 citationsPhase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.Julie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, Mark O'Hara, Elizabeth Hexner
Molecular Therapy. 2026-05-06
Other
- Clinical presentation, diagnosis, and staging of malignant pleural mesotheliomaAlbelda SM, Sterman DH, Kaiser LR, Litzky LA
http://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-of-malignant-pleural-me
UpToDate, Wolters Kluwer Health - 2013-01-16 - Epidemiology of malignant mesotheliomaAlbelda SM, Sterman DH, Kaiser LR, Litzky LA
http://www.uptodate.com/contents/epidemiology-of-malignant-mesothelioma
UpToDate, Wolters Kluwer Health - 2012-08-24 - Treatment approaches for localized malignant pleural mesothelioma and solitary fibrous tumor of the pleuraAlbelda SM, Sterman DH, Kaiser LR, Litzky LA
http://www.uptodate.com/contents/treatment-approaches-for-localized-malignant-pleural-mesothelioma-a
UpToDate, Wolters Kluwer Health - 2012-10-31
Press Mentions
After Revolutionizing Blood Cancer Care, CAR-T Therapy Takes Aim at Solid TumorsAugust 18th, 2025- Verismo Therapeutics Appoints Steven Albelda, MD, to Scientific Advisory BoardNovember 9th, 2021
Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for MesotheliomaSeptember 5th, 2019
Grant Support
- Training In Pulmonary ImmunologyNational Heart, Lung, And Blood Institute2000–2011
- Preclinical StudiesNational Cancer Institute2006–2010
- Immuno/Immunogene Therapies For Thoracic MalignanciesNational Cancer Institute2006–2010
- Genetic Influence On Incidence Of Acute Lung InjuryNational Heart, Lung, And Blood Institute2005–2009
- AdministrationNational Cancer Institute2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
